At a time when many insurance companies are looking to diversify and enter new markets to stimulate growth, Hartford Financial Services (NYSE:HIG) is looking to go in the other direction. Although exiting life insurance, retirement and annuities should both improve and stabilize returns over the long term, but it's likely going to take many years for the benefits to show up. While Hartford's current valuation seems to understate the core value in the business, investors could be looking at dead (or at least very sleepy) money for a while.

Investopedia Broker Guides: Enhance your trading with the tools from today's top online brokers.

Recent Results a Mixed Bag
Hartford's first quarter results highlight some of the challenges in the business right now. Reported per-share operating earnings up were up 11%, but deferred acquisition cost (DAC) benefits helped.

Commercial P&C net written premiums were a little soft (up 3%), despite good pricing in "small commercial" and worker's comp. Group benefits were a drag, though, as premiums declined 7% and earnings dropped on higher losses. Consumer NWP was soft as the company walked away from some business. Life and retirement results looked solid, but those are the businesses that Hartford is looking to sell.

SEE: The Most Important Metrics For Earnings Season

Can Hartford Get Good Value in Its Conversion to P&C?
In deciding to get out of the life, retirement and annuity businesses, Hartford is going to be moving to something closer to a pure P&C insurance company. That's not a bad idea in and of itself - companies like Hartford and AXA (OTC:AXAHY) have seen a lot of unexpected volatility from annuity businesses and life insurance is increasingly a commoditized business with unimpressive return potential.

It'll be interesting to see if Hartford can get good value for these units. MetLife (NYSE:MET), Prudential (NYSE:PRU) and Lincoln National (NYSE:LNC) would all be logical interested parties, but the relatively low valuation on those stocks increases the cost of capital for any prospective deal, and MetLife may have regulatory issues in launching a deal of that size (likely on the order of $2 billion).

It's also worth noting that the sale would not immediately improve results. Because of the company's need to deleverage the business and hedge the annuity run-off, returns on equity could easily stay in the high single digits for a while.

SEE: How Return On Equity Can Help You Find Profitable Stocks

A Change in Business Needs to Lead to a Change in Outlook
I also suspect that Hartford needs to change some of its operating philosophies with this restructuring effort. Hartford has built a good distribution system over the years, but I think the company sometimes puts a premium on market share. Hartford has been pretty aggressive in keeping its group benefits share, and that is likely part of the reason for the weaker results seen recently. Since disciplined underwriting is key to success in P&C, the company has to be more willing to walk away from business in the future if the pricing isn't right.

SEE: Great Expectations: Forecasting Sales Growth

The Bottom Line
There seems to be quite a bit of skepticism on this name right now, and that may be reasonable given the uncertainties over the timing of the restructuring efforts and the limited options for positive capital deployment. Said differently, Hartford is more likely to be playing defense than offense for the next couple of years and that leads to a less impressive book value growth outlook.

Still, if the company can deliver high single-digit returns on equity, then the shares are too cheap today. Investors are going to have to be patient to realize that value, though, and investors may have more compelling options for their money in the near term.

At the time of writing, Stephen D. Simpson did not own shares in any of the companies mentioned in this article.

Related Articles
  1. Investing

    How to Ballast a Portfolio with Bonds

    If January and early February performance is any guide, there’s a new normal in financial markets today: Heightened volatility.
  2. Stock Analysis

    Performance Review: Emerging Markets Equities in 2015

    Find out why emerging markets struggled in 2015 and why a half-decade long trend of poor returns is proving optimistic growth investors wrong.
  3. Investing

    Don't Freak Out Over Black Swans; Be Prepared

    Could 2016 be a big year for black swans? Who knows? Here's what black swans are, how they can devastate the unprepared, and how the prepared can emerge unscathed.
  4. Investing News

    Today's Sell-off: Are We in a Margin Liquidation?

    If we're in market liquidation, is it good news or bad news? That party depends on your timeframe.
  5. Investing News

    Bank Stocks: Time to Buy or Avoid? (WFC, JPM, C)

    Bank stocks have been pounded. Is this the right time to buy or should they be avoided?
  6. Stock Analysis

    Why the Bullish Are Turning Bearish

    Banks are reducing their targets for the S&P 500 for 2016. Here's why.
  7. Stock Analysis

    How to Find Quality Stocks Amid the Wreckage

    Finding companies with good earnings and hitting on all cylinders in this environment, although possible, is not easy.
  8. Stock Analysis

    Analyzing Sirius XM's Return on Equity (ROE) (SIRI)

    Learn more about the Sirius XM's overall 2015 performance, return on equity performance and future predictions for the company's ROE in 2016 and beyond.
  9. Budgeting

    5 Alternatives to Traditional Health Insurance

    Discover five of the most popular alternatives to traditional health insurance plans, alternatives that are increasingly popular as health insurance costs rise.
  10. Stock Analysis

    Will Virtusa Corporation's Stock Keep Chugging in 2016? (VRTU)

    Read a thorough review and analysis of Virtusa Corporation's stock looking to project how well the stock is likely to perform for investors in 2016.
RELATED FAQS
  1. When does a growth stock turn into a value opportunity?

    A growth stock turns into a value opportunity when it trades at a reasonable multiple of the company's earnings per share ... Read Full Answer >>
  2. What is the formula for calculating EBITDA?

    When analyzing financial fitness, corporate accountants and investors alike closely examine a company's financial statements ... Read Full Answer >>
  3. How do I calculate the P/E ratio of a company?

    The price-earnings ratio (P/E ratio) is a valuation measure that compares the level of stock prices to the level of corporate ... Read Full Answer >>
  4. How do you calculate return on equity (ROE)?

    Return on equity (ROE) is a ratio that provides investors insight into how efficiently a company (or more specifically, its ... Read Full Answer >>
  5. How do you calculate working capital?

    Working capital represents the difference between a firm’s current assets and current liabilities. The challenge can be determining ... Read Full Answer >>
  6. What is the formula for calculating the current ratio?

    The current ratio is a financial ratio that investors and analysts use to examine the liquidity of a company and its ability ... Read Full Answer >>
COMPANIES IN THIS ARTICLE
Trading Center